Exogenous administration of thiosulfate, a donor of hydrogen sulfide, attenuates angiotensin II-induced hypertensive heart disease in rats.
about
Biogenesis of reactive sulfur species for signaling by hydrogen sulfide oxidation pathwaysSodium hydrosulfide prevents myocardial dysfunction through modulation of extracellular matrix accumulation and vascular densitySulfide oxidation by a noncanonical pathway in red blood cells generates thiosulfate and polysulfidesHydrogen Sulfide: A Therapeutic Candidate for Fibrotic Disease?Role of Hydrogen Sulfide in Ischemia-Reperfusion Injury.Emerging role of hydrogen sulfide in hypertension and related cardiovascular diseasesBeyond a Gasotransmitter: Hydrogen Sulfide and Polysulfide in Cardiovascular Health and Immune Response.Hydrogen sulfide, an enhancer of vascular nitric oxide signaling: mechanisms and implications.Vascular biology of hydrogen sulfide.Cooperative Oxygen Sensing by the Kidney and Carotid Body in Blood Pressure Control.Pharmacology of the 'gasotransmitters' NO, CO and H2S: translational opportunities.Sodium hydrosulfide attenuates cerebral ischemia/reperfusion injury by suppressing overactivated autophagy in rats.Sodium Thiosulfate Preconditioning Ameliorates Ischemia/Reperfusion Injury in Rat Hearts Via Reduction of Oxidative Stress and Apoptosis.Maternal Renovascular Hypertensive Rats Treatment With Hydrogen Sulfide Increased the Methylation of AT1b Gene in Offspring.A timeline of hydrogen sulfide (H2S) research: From environmental toxin to biological mediator.International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors.An essential role for Wnt/β-catenin signaling in mediating hypertensive heart disease.Hydrogen Sulfide (HS)-Releasing Compounds: Therapeutic Potential in Cardiovascular Diseases
P2860
Q28601441-1AD58E36-A4FB-4FFA-BE2D-969DA952BCE6Q34835381-66791F7B-85F5-4FBD-B08E-92A657C0D2D5Q35221567-E68868B8-D384-4579-96B3-8268081EB785Q35640718-FBA82378-C93D-4D6C-A7E2-AA8FB54E51F6Q35647095-1768EAD9-578C-47B9-89CB-24BABF18F3ECQ36342111-75E5E8B1-74C4-4D87-B41D-84EF7B348BD0Q38732028-818C501B-7930-4A52-9938-E664DEE4AEBDQ38991916-7DF07FF9-5556-454B-B999-9A02C09C8E93Q39113984-58F582FB-841F-4A4C-89F5-8C13E8ADB7D3Q42372768-D047A648-E257-4850-863C-A697A195290DQ43197362-EFDE9079-A9B3-4B76-AC9E-08DE60F2EB88Q47169278-38ECB674-71F2-4595-8057-A0FC9E8ADEBAQ47614023-B15CC4A2-6954-4148-A4ED-91FB4C3D2AD4Q47687046-54DB17CB-DC1B-4A11-9F55-68410E05A1A9Q47762321-A4823ABC-680B-4CB8-9875-649033D0BE88Q47914860-3F90E8F4-0105-46A9-8FB7-A4CBFD287845Q55413374-3C972EC9-2DA0-4A20-8400-92C61FDBE70AQ57300054-4EE55F9D-476E-47D5-AF82-FDE595278FEE
P2860
Exogenous administration of thiosulfate, a donor of hydrogen sulfide, attenuates angiotensin II-induced hypertensive heart disease in rats.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Exogenous administration of th ...... tensive heart disease in rats.
@ast
Exogenous administration of th ...... tensive heart disease in rats.
@en
type
label
Exogenous administration of th ...... tensive heart disease in rats.
@ast
Exogenous administration of th ...... tensive heart disease in rats.
@en
prefLabel
Exogenous administration of th ...... tensive heart disease in rats.
@ast
Exogenous administration of th ...... tensive heart disease in rats.
@en
P2093
P2860
P356
P1476
Exogenous administration of th ...... tensive heart disease in rats.
@en
P2093
A R Frenay
H van Goor
J L Hillebrands
P M Snijder
R A de Boer
P2860
P304
P356
10.1111/BPH.12825
P407
P50
P577
2015-03-01T00:00:00Z